LTFS
BMY.RT

Ladenburg Thalmann Financial Services’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$70K Buy
+22,311
New +$58K ﹤0.01% 3300

Other funds holding BMY.RT

LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ladenburg Thalmann Financial Services's BMY.RT Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services opened a new position in Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q4 2019: 22,311 shares worth $70K. The stake represents ﹤0.01% of the portfolio and ranks #3300 among its holdings.

616 funds tracked by Wall St. Rank hold BMY.RT as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 22,311 shares of Bristol-Myers Squibb Company Contingent Value Rights worth $70K as of Q4 2019.
  • Bristol-Myers Squibb Company Contingent Value Rights was a new Ladenburg Thalmann Financial Services position in Q4 2019.
  • Bristol-Myers Squibb Company Contingent Value Rights made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3300 holding.
  • 616 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.